Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Blocking Interaction of Apurinic/apyrimidinic Endonuclease and DNA Secondary Structure G-quadruplex Suppresses Triple-Negative Breast Cancer Metastasis

ABSTRACT: Triple-negative breast cancer (TNBC) is the most aggressive and highly metastatic breast cancer. Recent genome-wide analyses have identified significant alterations in non-canonical four-stranded DNA secondary structures, G-quadruplexes (G4), within promoter and enhancer regions of genes linked to metastatic TNBC. The mechanistic link between G4 DNA and TNBC metastasis, however, remains unclear. Using CRISPR to genetically abrogate G4 folding at the endogenous gene promoters in TNBC cells, we demonstrate that loss of G4 structure in CXCL1 gene promoter significantly reduces CXCL1 expression, consequently a significant decrease in cell migration and invasion, as well as in vivo tumorigenesis and lung metastasis. Mechanistically, G4 recruits APE1, a multifunctional protein that enhances transcription factors binding through its redox-effector function and activates key metastasis-associated genes. Further, APE1 deletion or disruption of its binding to G4 with TMPyP4, a G4 ligand, suppresses gene expression, tumor growth, and lung metastasis. Our study provides the first genetic evidence of G4's role in tumor progression and metastasis and identifies the G4:APE1 axis as a novel therapeutic target to target TNBC primary tumor and metastasis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE297827 | GEO | 2026/04/09

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	GSE297827_RAW.tar	Raw
	GSE297827_deseqresults_ctlvmdmaKD.txt.gz	Txt
	GSE297827_gene_count_matrix_mdmb.csv.gz	Csv
	GSE297827_transcript_count_matrix_mdmb.csv.gz	Csv

Items per page:

1 - 5 of 6

Similar Datasets

APE1 (apurinic/apyrimidinic endonuclease 1): newly identified post-translational modifications (PTMs)

Project description:APE1 (apurinic/apyrimidinic endonuclease 1) is a multifunctional protein essential for both DNA base excision repair and redox signaling. However, its post-translational modifications (PTMs), which are key to modulating its cellular functions, remain largely uncharacterized due to their dynamic and labile nature. In this study, we developed a novel biotin-regulated avidin-based magnetic nanoparticle platform (bMIPAPE1) that selectively captures active APE1 from living cells under native conditions. This approach preserves labile PTMs and enables downstream mass spectrometry-based proteomic analysis. Using this tool, we identified 27 previously unreported PTMs at 18 distinct residues, including modifications with critical functional implications, such as phosphorylation at Y269 and dual acetylation/palmitoylation at K228. Furthermore, we uncovered PTMs associated with subcellular localization, including modifications at K203, C208, and K63 that correlated with APE1 nuclear export. Beyond enrichment and profiling, bMIPAPE1 also inhibits the enzymatic functions of APE1 in cells, offering potential therapeutic relevance. This project showcases an innovative method for real-time PTM profiling of endogenous proteins in complex cellular environments, with implications for cancer biology and targeted drug discovery.

2026-03-17 | PXD067266 | Pride

Clinical significance of apurinic/apyrimidinic endodeoxyribonuclease 1 and microRNAs axis in hepatocellular carcinoma [NanoString]

Project description:Hepatocellular carcinoma is the most frequent species of liver cancer and the identification of new prognostic factors opens new perspectives for therapy. Circulating and cellular onco-miRNAs are non coding RNAs which can control oncogenesis-related gene expression through post-transcriptional mechanisms and are considered novel prognostic and predictive factors in cancer biology. The apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) contributes in the quality control and processing of specific onco-miRNAs, and is a negative prognostic factor in many tumors. The present work aims: a) to define APE1 prognostic value in HCC; b) to identify miRNAs regulated by APE1 and their relative target genes, and c) to study their prognostic value.

2023-09-21 | GSE222851 | GEO

Clinical significance of apurinic/apyrimidinic endodeoxyribonuclease 1 and microRNAs axis in hepatocellular carcinoma [RNA-Seq]

2023-09-21 | GSE222852 | GEO

Apurinic/apyrimidinic endonuclease/redox factor-1 (Ape1/Ref-1) activates Notch signaling through Jagged1 expression and promotes colon cancer progression

Project description:To investigate the possible role of Ape1/Ref-1 in tumorigenicity of colon cancer and explored the oncogenic mechanism of Ape1/Ref-1 in colon cancer cells. Control and Ref-1 overexpressing SW480cells, control and Ref-1-deficient SW480 cells. Duplicate

2013-04-17 | E-GEOD-45912 | biostudies-arrayexpress

Apurinic/apyrimidinic endonuclease/redox factor-1 (Ape1/Ref-1) activates Notch signaling through Jagged1 expression and promotes colon cancer progression

Project description:To investigate the possible role of Ape1/Ref-1 in tumorigenicity of colon cancer and explored the oncogenic mechanism of Ape1/Ref-1 in colon cancer cells.

2013-04-17 | GSE45912 | GEO

Human apurinic/apyrimidinic endonuclease 1.

Project description:SignificanceHuman apurinic/apyrimidinic endonuclease 1 (APE1, also known as REF-1) was isolated based on its ability to cleave at AP sites in DNA or activate the DNA binding activity of certain transcription factors. We review herein topics related to this multi-functional DNA repair and stress-response protein.Recent advancesAPE1 displays homology to Escherichia coli exonuclease III and is a member of the divalent metal-dependent α/β fold-containing phosphoesterase superfamily of enzymes. APE1 has acquired distinct active site and loop elements that dictate substrate selectivity, and a unique N-terminus which at minimum imparts nuclear targeting and interaction specificity. Additional activities ascribed to APE1 include 3'-5' exonuclease, 3'-repair diesterase, nucleotide incision repair, damaged or site-specific RNA cleavage, and multiple transcription regulatory roles.Critical issuesAPE1 is essential for mouse embryogenesis and contributes to cell viability in a genetic background-dependent manner. Haploinsufficient APE1(+/-) mice exhibit reduced survival, increased cancer formation, and cellular/tissue hyper-sensitivity to oxidative stress, supporting the notion that impaired APE1 function associates with disease susceptibility. Although abnormal APE1 expression/localization has been seen in cancer and neuropathologies, and impaired-function variants have been described, a causal link between an APE1 defect and human disease remains elusive.Future directionsOngoing efforts aim at delineating the biological role(s) of the different APE1 activities, as well as the regulatory mechanisms for its intra-cellular distribution and participation in diverse molecular pathways. The determination of whether APE1 defects contribute to human disease, particularly pathologies that involve oxidative stress, and whether APE1 small-molecule regulators have clinical utility, is central to future investigations.

| S-EPMC3901322 | biostudies-literature

APE1 regulates the transcription of urea cycle genes through stabilizing DNA G-quadruplexes in lung adenocarcinoma [ATAC-seq]

Project description:Lung adenocarcinoma (LUAD) remains the leading cause of cancer deaths worldwide. Apurinic/apyrimidinic endonuclease 1 (APE1), an enzyme integral to DNA repair and redox signaling, is notably upregulated in various cancers, including LUAD. Here we reveal that APE1 amplification, primarily via allele duplication, correlates with poor prognosis in LUAD patients strongly. Using human LUAD cell models and a KRAS-driven genetically engineered mouse model (GEMM), we show that APE1 deletion hampers cell proliferation and tumor growth, highlighting its role in tumorigenesis. Mechanistically, APE1 promoted the transcription of urea cycle genes CPS1 and ARG2 by modulating the presence of G-quadruplex (G4) structures in their promoter regions. Loss of APE1 disrupts the urea cycle and pyrimidine metabolism, inducing metabolic reprogramming and growth arrest, which can be rescued by CPS1 or pyrimidine restoration. These findings uncover APE1’s role in metabolic regulation via G4-mediated transcription, providing a potential therapeutic target LUAD patients with elevated APE1 expression.

2024-12-06 | GSE271726 | GEO